Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| NeoVolta Inc.NEOV · Entity 6227 | 10% owner | October 08, 2025 | October 10, 2025 |
| Rapid Therapeutic Science Laboratories, Inc.HLLY · Entity 131925 | Director · CEO and President · 10% owner | January 29, 2018 | February 21, 2018 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
NeoVolta Inc.
Report date October 08, 2025 · Filed October 10, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectSee Footnote 2 | 3,550,000 |
Reported balance
After 2025-10-08 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2025-10-08 · Sale · Disposed 500,000 · Balance 3,550,000 F1: The shares were sold in a private transaction and are deemed to be "restricted securities" pursuant to the Securities Act of 1933, as amended. F2: Includes 3,500,000 shares held by Canmore International, Inc., an entity affiliated with the reporting person, and 50,000 shares held directly by the reporting person. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares were sold in a private transaction and are deemed to be "restricted securities" pursuant to the Securities Act of 1933, as amended.
F2: Includes 3,500,000 shares held by Canmore International, Inc., an entity affiliated with the reporting person, and 50,000 shares held directly by the reporting person.
Rapid Therapeutic Science Laboratories, Inc.
Report date January 29, 2018 · Filed February 21, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 750,000 |
Reported balance
After 2018-01-29 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2018-01-29 · Grant · Acquired 750,000 · Balance 750,000 F1: Contemporaneous with Colonel Willson's execution of his employment agreement with the Company, Col. Willson purchased from the Company 750,000 shares of Company common stock at a purchase price of $0.001 per share; provided that if Col. Willson's employment with the Company is terminated the Company has the right to repurchase from Col. Willson, at a purchase price of $0.05 per share, such number of purchased shares as is equal to 750,000 multiplied by "X" divided by 36, where "X" equals 36 minus the number of whole months Col. Willson has provided services to the Company; provided further that if the Company terminates Col. Willson for "cause" all purchased shares may be repurchased by the Company for the initial purchase price paid by the Company. |
Filing footnotes · ownership attribution and instrument terms
F1: Contemporaneous with Colonel Willson's execution of his employment agreement with the Company, Col. Willson purchased from the Company 750,000 shares of Company common stock at a purchase price of $0.001 per share; provided that if Col. Willson's employment with the Company is terminated the Company has the right to repurchase from Col. Willson, at a purchase price of $0.05 per share, such number of purchased shares as is equal to 750,000 multiplied by "X" divided by 36, where "X" equals 36 minus the number of whole months Col. Willson has provided services to the Company; provided further that if the Company terminates Col. Willson for "cause" all purchased shares may be repurchased by the Company for the initial purchase price paid by the Company.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 08, 2025 Filed Oct 10, 2025 18:32 UTC | NeoVolta Inc. NEOV · Entity 6227 | SaleCommon Stock | 500,000 | $0.01 | $5,000.00 |
DisclosureSEC source: 0001683168-25-007510 · ownership.xml · nonDerivative · entry 1 Willson Brent · CIK 0001731873 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote 2 Disclosed balance after: 3,550,000 F1 · price: The shares were sold in a private transaction and are deemed to be "restricted securities" pursuant to the Securities Act of 1933, as amended. F2 · ownership.direct: Includes 3,500,000 shares held by Canmore International, Inc., an entity affiliated with the reporting person, and 50,000 shares held directly by the reporting person. Read SEC document |
| January 01, 2023 Filed Jan 4, 2023 20:09 UTC | NeoVolta Inc. NEOV · Entity 6227 | Exercise / conversionRestricted Stock Units · Derivative | 50,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001683168-23-000031 · ownership.xml · derivative · entry 2 Willson Brent · CIK 0001731873 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 50,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The reporting person was granted 300,000 restricted stock units (RSUs), vesting as follows: (i) 50,000 of the RSUs vested on January 1, 2023; and (ii) 100,000 RSUs shall vest shall vest on the occurrence of both of the following events: (A) the Company producing at least 2,000 energy storage systems during 2022; and (B) the earliest of (1) a change in control or (2) the termination of the reporting person's employment by the Company without cause (as defined in the employment agreement between the Company and reporting person dated on or about the date hereof) or (3) the death of reporting person, or (4) January 1, 2023, provided the reporting person is serving as an employee of the Company on such date. F1 · price: Issued upon conversion of restricted stock units that convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: The reporting person was granted 300,000 restricted stock units (RSUs), vesting as follows: (i) 50,000 of the RSUs vested on January 1, 2023; and (ii) 100,000 RSUs shall vest shall vest on the occurrence of both of the following events: (A) the Company producing at least 2,000 energy storage systems during 2022; and (B) the earliest of (1) a change in control or (2) the termination of the reporting person's employment by the Company without cause (as defined in the employment agreement between the Company and reporting person dated on or about the date hereof) or (3) the death of reporting person, or (4) January 1, 2023, provided the reporting person is serving as an employee of the Company on such date. F2 · derivative.expiration_date: The reporting person was granted 300,000 restricted stock units (RSUs), vesting as follows: (i) 50,000 of the RSUs vested on January 1, 2023; and (ii) 100,000 RSUs shall vest shall vest on the occurrence of both of the following events: (A) the Company producing at least 2,000 energy storage systems during 2022; and (B) the earliest of (1) a change in control or (2) the termination of the reporting person's employment by the Company without cause (as defined in the employment agreement between the Company and reporting person dated on or about the date hereof) or (3) the death of reporting person, or (4) January 1, 2023, provided the reporting person is serving as an employee of the Company on such date. Read SEC document |
| January 01, 2023 Filed Jan 4, 2023 20:09 UTC | NeoVolta Inc. NEOV · Entity 6227 | Exercise / conversionCommon Stock | 50,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001683168-23-000031 · ownership.xml · nonDerivative · entry 1 Willson Brent · CIK 0001731873 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Issued upon conversion of restricted stock units that convert into common stock on a one-for-one basis. F3 · ownership.direct: Does not include 4,000,000 shares held by Canmore International, Inc., an entity affiliated with the reporting person. Read SEC document |
| January 29, 2018 Filed Feb 21, 2018 15:46 UTC | Rapid Therapeutic Science Laboratories, Inc. HLLY · Entity 131925 | GrantCommon Stock | 750,000 | $0.00 | $750.00 |
DisclosureSEC source: 0001393905-18-000070 · primary_doc.xml · nonDerivative · entry 1 Willson Brent · CIK 0001731873 · Director · CEO and President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 750,000 F1 · shares: Contemporaneous with Colonel Willson's execution of his employment agreement with the Company, Col. Willson purchased from the Company 750,000 shares of Company common stock at a purchase price of $0.001 per share; provided that if Col. Willson's employment with the Company is terminated the Company has the right to repurchase from Col. Willson, at a purchase price of $0.05 per share, such number of purchased shares as is equal to 750,000 multiplied by "X" divided by 36, where "X" equals 36 minus the number of whole months Col. Willson has provided services to the Company; provided further that if the Company terminates Col. Willson for "cause" all purchased shares may be repurchased by the Company for the initial purchase price paid by the Company. F1 · balance_after: Contemporaneous with Colonel Willson's execution of his employment agreement with the Company, Col. Willson purchased from the Company 750,000 shares of Company common stock at a purchase price of $0.001 per share; provided that if Col. Willson's employment with the Company is terminated the Company has the right to repurchase from Col. Willson, at a purchase price of $0.05 per share, such number of purchased shares as is equal to 750,000 multiplied by "X" divided by 36, where "X" equals 36 minus the number of whole months Col. Willson has provided services to the Company; provided further that if the Company terminates Col. Willson for "cause" all purchased shares may be repurchased by the Company for the initial purchase price paid by the Company. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.